首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1324913

人工唾液市场：现状分析与预测（2022-2028）

Artificial Saliva Market: Current Analysis and Forecast (2022-2028)

出版日期: 2023年07月31日 | 出版商:

UnivDatos Market Insights Pvt Ltd | 英文 142 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录

您的医生可能还会建议将人工唾液与已知会导致口干的药物或医疗程序一起使用，例如止痛药或化疗。例如，美国国家癌症研究所 (NIH) 估计，2022 年美国将有 1810 万癌症倖存者。这约占总人口的 5.4%，预计到 2032 年将增加 24.4%，达到 2250 万人。

由于癌症患者吞嚥困难的患病率不断增加，人工唾液市场预计将以 13% 左右的速度稳定增长。此外，发达国家和新兴国家口腔疾病治疗费用高昂、可支配收入增加和人均支出增加也将支持预测期内的市场增长。

根据产品类型，市场分为口腔喷雾剂、口服液、口服液、凝胶和粉末。口腔喷雾剂在预测期内的复合年增长率最高。这主要是因为易于使用、高效且成本低廉，并且这些喷雾剂通常用于治疗口干病症。此外，主要参与者增加产品开发正在推动该细分市场的增长。例如，Parnell Pharmaceuticals, Inc. 于 2021 年推出了 Mouth Kote-MD，这是一种基于 MycoDelens 的口腔喷雾剂，MycoDelens 是新墨西哥理工学院创建并获得许可的专有物质。

按年龄段划分，市场分为成人和儿童。其中，成人品类主导了2020年人工唾液市场的增长。这主要是因为人工唾液在成人患者中使用得更频繁，而口干症状通常在成人患者中比儿童患者更常见，所以我们认为这种情况不会很快改变。我会的。

导致该细分市场增长的另一个因素是口腔癌和食道癌引起的吞嚥困难的增加。例如，根据世界癌症研究基金会（WCRF International）的数据，2020 年大约诊断出 604,100 例食管癌新病例。

人工唾液市场按分销渠道分为医院药房、零售药房、超市和大卖场等。零售药店在预测期内将经历最高的增长。这主要是由于药品的可负担性以及人口的不断增长，导致糖尿病、中风、阿尔茨海默氏病、干燥综合症和艾滋病毒/艾滋病病例不断增加，这些都会导致口干症。例如，根据国际糖尿病联盟 (IDF) 的数据，到 2021 年，大约有 120 万年轻人和青少年将患有 1 型糖尿病。

为了更好地了解人工唾液行业的市场实施情况，将市场分为北美（美国、加拿大、北美其他地区）、欧洲（德国、英国、法国、西班牙、意大利、欧洲其他地区）、亚太地区（中国、日本、印度、亚太地区其他地区）和世界其他国家。预计北美地区在预测期内将以显着的复合年增长率增长。这主要是由于市场上主要参与者的存在、人们对口腔疾病的认识不断提高、治疗口干症的产品的使用增加、可支配收入的增加、癌症和阿尔茨海默氏病患病率的增加、技术的进步以及患者人数的增加预计将促进市场增长。例如，根据美国国家慢性病预防中心 (CDC) 的数据，2020 年有 580 万美国人患有阿尔茨海默病。

Chewing, swallowing, digesting, and speaking all depend on saliva. Additionally, it controls bacteria growth in the mouth & reducing the risk of infection and tooth decay. While primarily water, natural saliva also contains mucous, enzymes, and electrolytes. Although artificial saliva doesn't exactly like the saliva that our glands normally create, the combination of its ingredients can help relieve symptoms like bad breath and a feeling of dryness or stickiness in the mouth.

Also, doctors may recommend the use of artificial saliva alongside medications and medical treatments, such as pain medications and chemotherapy, that are known to cause dry mouth. For instance, according to the National Cancer Institute (NIH), in 2022, it is estimated that there are 18.1 million cancer survivors in the United States. This represents approximately 5.4% of the population and it is projected to increase by 24.4%, to 22.5 million, by 2032.

The artificial saliva market is expected to grow at a steady rate of around 13% owing to the increasing prevalence of dysphagia condition in cancer patients. Also, the expensive treatments for oral diseases in both developed & developing countries and the growing disposable income and increasing per-capita spending drive the growth of the market during the forecast period.

Based on product type, the market is segmented into oral spray, oral solution, oral liquid, gel, and powder. The oral spray category is to witness the highest CAGR during the forecast period. This is mainly due to their ease of use, efficiency & low cost, and these sprays are commonly used to treat dry mouth conditions. Also, increasing product development by key players drives the growth of the segment. For instance, Mouth Kote-MD, a mouth spray based on MycoDelens, a proprietary substance created and licensed by New Mexico Tech University, was presented by Parnell Pharmaceuticals, Inc. in 2021.

On the basis of age group, the market is bifurcated into adult and pediatric. Among these, the adult category dominated the growth of the artificial saliva market in 2020. This is mainly due to the artificial saliva being used more by adult patients and this is unlikely to change anytime soon as the dry mouth condition is typically more common in adult patients than pediatric ones.

The other factor for the growth of this segment is the growing dysphagia condition due to mouth cancer or oesophageal cancer. For instance, according to the World Cancer Research Fund (WCRF International), around 604,100 new cases of oesophageal cancer were diagnosed in 2020.

Based on distribution channel, the artificial saliva market has been classified into hospital pharmacies, retail pharmacies, supermarkets & hypermarkets, and others. The retail pharmacies category is to witness the highest growth during the forecast period. This is mainly due to the affordability of medicines and the growing population with rising cases of diabetes, stroke, Alzheimer's disease, Sjogren's syndrome, or HIV/AIDS which will cause dry mouth conditions. For instance, as per the International Diabetes Federation (IDF), around 1.2 million youngsters and youths have type 1 diabetes in 2021.

For a better understanding of the market adoption of the artificial saliva industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is anticipated to grow at a substantial CAGR during the forecast period. This is mainly due to the availability of major market key players, rising awareness about oral diseases, growing product utilization to treat xerostomia, rising disposable incomes, increasing prevalence of cancer and Alzheimer's disease, growing technological advancements, and presence of a large patient population in the region, which is expected to aid the market growth. For instance, according to the National Center for Chronic Disease Prevention (CDC), in 2020, as many as 5.8 million Americans were living with Alzheimer's disease.

Some of the major players operating in the market include: GSK plc.; Cipla Inc.; Mission Pharmacal Company; Fresenius Kabi AG; Parnell Pharmaceuticals, Inc.; CCMed Ltd.; ENTOD INTERNATIONAL; Midatech Pharma PLC; Forward Science; Bausch Health Companies Inc.

1 MARKET INTRODUCTION

1.1. Market Definitions
1.2. Main Objective
1.3. Stakeholders
1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1. Research Process of the Artificial Saliva Market
2.2. Research Methodology of the Artificial Saliva Market
2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE ARTIFICIAL SALIVA MARKET

6 ARTIFICIAL SALIVA MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY PRODUCT TYPE

7.1. Oral Spray
7.2. Oral Solution
7.3. Oral Liquid
7.4. Gel
7.5. Powder

8 MARKET INSIGHTS BY AGE GROUP

8.1. Adult
8.2. Paediatric

9 MARKET INSIGHTS BY DISTRIBUTION CHANNEL

9.1. Hospital Pharmacies
9.2. Retail Pharmacies
9.3. Others

10 MARKET INSIGHTS BY REGION

10.1. North America
- 10.1.1. U.S.
- 10.1.2. Canada
- 10.1.3. Rest of North America
10.2. Europe
- 10.2.1. Germany
- 10.2.2. U.K.
- 10.2.3. France
- 10.2.4. Italy
- 10.2.5. Spain
- 10.2.6. Rest of Europe
10.3. Asia-Pacific
- 10.3.1. China
- 10.3.2. Japan
- 10.3.3. India
- 10.3.4. Rest of Asia-Pacific
10.4. Rest of World

11 ARTIFICIAL SALIVA MARKET DYNAMICS

11.1. Market Drivers
11.2. Market Challenges
11.3. Impact Analysis

12 ARTIFICIAL SALIVA MARKET OPPORTUNITIES

13 ARTIFICIAL SALIVA MARKET TRENDS

14 DEMAND AND SUPPLY-SIDE ANALYSIS

14.1. Demand Side Analysis
14.2. Supply Side Analysis

15 VALUE CHAIN ANALYSIS

16 PRICING ANALYSIS

17 STRATEGIC INSIGHTS

18 COMPETITIVE SCENARIO

18.1. Competitive Landscape
- 18.1.1. Porters Fiver Forces Analysis

19 COMPANY PROFILED

19.1. GSK plc.
19.2. Cipla Inc.
19.3. Mission Pharmacal Company
19.4. Fresenius Kabi AG
19.5. Parnell Pharmaceuticals, Inc.
19.6. CCMed Ltd.
19.7. ENTOD INTERNATIONAL
19.8. Midatech Pharma PLC
19.9. Forward Science
19.10. Bausch Health Companies Inc.

20 DISCLAIMER

02-2729-4219

+886-2-2729-4219

License/价格

人工唾液市场：现状分析与预测（2022-2028）

Artificial Saliva Market: Current Analysis and Forecast (2022-2028)

目录

第一章市场介绍

第二章研究方法或假设

第三章市场总结

第 4 章执行摘要

第五章 COVID-19 对人工唾液市场的影响

第六章人工唾液市场收入，2020-2028

第 7 章按产品类型划分的市场洞察

第 8 章按年龄段划分的市场洞察

第 9 章按分销渠道划分的市场洞察

第 10 章按地区划分的市场洞察

第11章人工唾液市场动态

第12章人工唾液市场机会

第13章人工唾液市场趋势

第14章需求侧和供给侧分析

第 15 章价值链分析

第16章价格分析

第 17 章战略洞察

第18章竞争场景

第19章公司简介

第20章 免责事项

TABLE OF CONTENTS